P&G OTC medicines volume up 9%, paced by Vicks, Pepto-Bismol, Metamucil.
This article was originally published in The Tan Sheet
Executive Summary
P&G OTC MEDICINES VOLUME UP 9%, LED BY VICKS, PEPTO, METAMUCIL in the first quarter of FY 1998 (ended Sept. 30). P&G's healthcare segment volume increased 2%, paced by the Vicks respiratory line and gastrointestinal products such as Pepto-Bismol and the laxative Metamucil. Pharmaceuticals also aided the segment's sales growth, with an Rx volume gain of 12%.